Prudential Financial
PVLA

Prudential Financial’s Palvella Therapeutics PVLA Stock Holding History

Prudential Financial’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,760
Closed -$40.5K – 2809
2024
Q1 		$40.5K Buy
2,760
+1,382
+100% +$19.2K ﹤0.01% 2610
2023
Q4 		$20.1K Hold
1,378
– – ﹤0.01% 2617
2023
Q3 		$32.8K Buy
1,378
+1,230
+831% +$26.4K ﹤0.01% 2541
2023
Q2 		$1.95K Buy
148
+3
+2% +$182 ﹤0.01% 2611
2023
Q1 		$11.3K Hold
145
– – ﹤0.01% 2584
2022
Q4 		$12.1K Hold
145
– – ﹤0.01% 2575
2022
Q3 		$13K Hold
145
– – ﹤0.01% 2638
2022
Q2 		$22K Buy
+145
New +$26.5K ﹤0.01% 2643
2021
Q1 		– Sell
-134
Closed -$26K – 2541
2020
Q4 		$26K Hold
134
– – ﹤0.01% 2430
2020
Q3 		$22K Sell
134
-352
-72% -$80.1K ﹤0.01% 2418
2020
Q2 		$121K Buy
+486
New +$114K ﹤0.01% 2320
2019
Q3 		– Sell
-134
Closed -$50K – 2482
2019
Q2 		$50K Buy
134
+1
+0.8% +$298 ﹤0.01% 2421
2019
Q1 		$36K Sell
133
-70
-34% -$16.6K ﹤0.01% 2409
2018
Q4 		$43K Buy
+203
New +$63K ﹤0.01% 2339

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Prudential Financial's PVLA Position: Q2 2024 in Review

Prudential Financial sold out of Palvella Therapeutics (PVLA) in Q2 2024, closing a stake of 2,760 shares — an estimated $40.5K sold.

Prudential Financial first reported a position in PVLA in Q4 2018 and held it in 14 quarters. The position peaked at $121K in Q2 2020. 21 funds tracked by Wall St. Rank hold PVLA as of Q2 2024.

  • Prudential Financial reported no remaining Palvella Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Prudential Financial sold 2,760 Palvella Therapeutics shares in Q2 2024, an estimated $40.5K.
  • Prudential Financial first reported a position in Palvella Therapeutics in Q4 2018 and held it in 14 quarters.
  • Prudential Financial's Palvella Therapeutics position peaked at $121K in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2024.

Based on Prudential Financial's 13F filing for Q2 2024, filed 13 Aug 2024.